nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilazapril—ABCB1—Tamoxifen—pancreatic cancer	0.0909	0.199	CbGbCtD
Cilazapril—ABCB1—Gemcitabine—pancreatic cancer	0.0783	0.172	CbGbCtD
Cilazapril—ABCB1—Erlotinib—pancreatic cancer	0.0773	0.169	CbGbCtD
Cilazapril—ABCB1—Irinotecan—pancreatic cancer	0.0698	0.153	CbGbCtD
Cilazapril—ABCB1—Docetaxel—pancreatic cancer	0.0512	0.112	CbGbCtD
Cilazapril—ABCB1—Sunitinib—pancreatic cancer	0.0509	0.112	CbGbCtD
Cilazapril—ABCB1—Doxorubicin—pancreatic cancer	0.0381	0.0835	CbGbCtD
Cilazapril—Mitiglinide—PPARG—pancreatic cancer	0.00251	0.662	CrCbGaD
Cilazapril—Nateglinide—PPARG—pancreatic cancer	0.00128	0.337	CrCbGaD
Cilazapril—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000491	0.00091	CcSEcCtD
Cilazapril—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00049	0.000909	CcSEcCtD
Cilazapril—Bronchitis—Epirubicin—pancreatic cancer	0.00049	0.000908	CcSEcCtD
Cilazapril—Anaemia—Docetaxel—pancreatic cancer	0.000486	0.000902	CcSEcCtD
Cilazapril—Vomiting—Sunitinib—pancreatic cancer	0.00048	0.000889	CcSEcCtD
Cilazapril—Dysuria—Epirubicin—pancreatic cancer	0.000476	0.000883	CcSEcCtD
Cilazapril—Neutropenia—Epirubicin—pancreatic cancer	0.000476	0.000883	CcSEcCtD
Cilazapril—Rash—Sunitinib—pancreatic cancer	0.000476	0.000882	CcSEcCtD
Cilazapril—Dermatitis—Sunitinib—pancreatic cancer	0.000475	0.000881	CcSEcCtD
Cilazapril—Urticaria—Fluorouracil—pancreatic cancer	0.000473	0.000876	CcSEcCtD
Cilazapril—Headache—Sunitinib—pancreatic cancer	0.000472	0.000876	CcSEcCtD
Cilazapril—Syncope—Docetaxel—pancreatic cancer	0.000472	0.000875	CcSEcCtD
Cilazapril—Leukopenia—Docetaxel—pancreatic cancer	0.000471	0.000873	CcSEcCtD
Cilazapril—Pollakiuria—Epirubicin—pancreatic cancer	0.000471	0.000872	CcSEcCtD
Cilazapril—Palpitations—Docetaxel—pancreatic cancer	0.000465	0.000862	CcSEcCtD
Cilazapril—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000465	0.000862	CcSEcCtD
Cilazapril—Loss of consciousness—Docetaxel—pancreatic cancer	0.000462	0.000857	CcSEcCtD
Cilazapril—Pancreatitis—Doxorubicin—pancreatic cancer	0.000462	0.000857	CcSEcCtD
Cilazapril—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000459	0.000852	CcSEcCtD
Cilazapril—Cough—Docetaxel—pancreatic cancer	0.000459	0.000851	CcSEcCtD
Cilazapril—Angina pectoris—Doxorubicin—pancreatic cancer	0.000459	0.000851	CcSEcCtD
Cilazapril—Hypersensitivity—Irinotecan—pancreatic cancer	0.000458	0.000848	CcSEcCtD
Cilazapril—Hypertension—Docetaxel—pancreatic cancer	0.000454	0.000842	CcSEcCtD
Cilazapril—Bronchitis—Doxorubicin—pancreatic cancer	0.000453	0.00084	CcSEcCtD
Cilazapril—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.00045	0.000835	CcSEcCtD
Cilazapril—Arthralgia—Docetaxel—pancreatic cancer	0.000448	0.00083	CcSEcCtD
Cilazapril—Chest pain—Docetaxel—pancreatic cancer	0.000448	0.00083	CcSEcCtD
Cilazapril—Myalgia—Docetaxel—pancreatic cancer	0.000448	0.00083	CcSEcCtD
Cilazapril—Nausea—Sunitinib—pancreatic cancer	0.000448	0.00083	CcSEcCtD
Cilazapril—Renal failure—Epirubicin—pancreatic cancer	0.000446	0.000828	CcSEcCtD
Cilazapril—Asthenia—Irinotecan—pancreatic cancer	0.000446	0.000826	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000445	0.000825	CcSEcCtD
Cilazapril—Conjunctivitis—Epirubicin—pancreatic cancer	0.000441	0.000818	CcSEcCtD
Cilazapril—Dysuria—Doxorubicin—pancreatic cancer	0.000441	0.000817	CcSEcCtD
Cilazapril—Neutropenia—Doxorubicin—pancreatic cancer	0.000441	0.000817	CcSEcCtD
Cilazapril—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000438	0.000813	CcSEcCtD
Cilazapril—Dry mouth—Docetaxel—pancreatic cancer	0.000438	0.000812	CcSEcCtD
Cilazapril—Pollakiuria—Doxorubicin—pancreatic cancer	0.000435	0.000807	CcSEcCtD
Cilazapril—Asthenia—Gemcitabine—pancreatic cancer	0.000434	0.000805	CcSEcCtD
Cilazapril—Confusional state—Docetaxel—pancreatic cancer	0.000433	0.000803	CcSEcCtD
Cilazapril—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.00043	0.000797	CcSEcCtD
Cilazapril—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.00043	0.000796	CcSEcCtD
Cilazapril—Oedema—Docetaxel—pancreatic cancer	0.000429	0.000796	CcSEcCtD
Cilazapril—Epistaxis—Epirubicin—pancreatic cancer	0.000428	0.000794	CcSEcCtD
Cilazapril—Pruritus—Gemcitabine—pancreatic cancer	0.000428	0.000794	CcSEcCtD
Cilazapril—Sinusitis—Epirubicin—pancreatic cancer	0.000426	0.00079	CcSEcCtD
Cilazapril—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000425	0.000788	CcSEcCtD
Cilazapril—Diarrhoea—Irinotecan—pancreatic cancer	0.000425	0.000788	CcSEcCtD
Cilazapril—Agranulocytosis—Epirubicin—pancreatic cancer	0.000424	0.000786	CcSEcCtD
Cilazapril—Shock—Docetaxel—pancreatic cancer	0.000423	0.000783	CcSEcCtD
Cilazapril—Pruritus—Fluorouracil—pancreatic cancer	0.000421	0.00078	CcSEcCtD
Cilazapril—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00042	0.000779	CcSEcCtD
Cilazapril—Tachycardia—Docetaxel—pancreatic cancer	0.000419	0.000777	CcSEcCtD
Cilazapril—Skin disorder—Docetaxel—pancreatic cancer	0.000417	0.000773	CcSEcCtD
Cilazapril—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000417	0.000772	CcSEcCtD
Cilazapril—Bradycardia—Epirubicin—pancreatic cancer	0.000415	0.000769	CcSEcCtD
Cilazapril—Diarrhoea—Gemcitabine—pancreatic cancer	0.000414	0.000768	CcSEcCtD
Cilazapril—Renal failure—Doxorubicin—pancreatic cancer	0.000413	0.000766	CcSEcCtD
Cilazapril—Dizziness—Irinotecan—pancreatic cancer	0.000411	0.000762	CcSEcCtD
Cilazapril—Anorexia—Docetaxel—pancreatic cancer	0.000409	0.000759	CcSEcCtD
Cilazapril—Rhinitis—Epirubicin—pancreatic cancer	0.000409	0.000758	CcSEcCtD
Cilazapril—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000408	0.000757	CcSEcCtD
Cilazapril—Diarrhoea—Fluorouracil—pancreatic cancer	0.000407	0.000755	CcSEcCtD
Cilazapril—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000406	0.000752	CcSEcCtD
Cilazapril—Pharyngitis—Epirubicin—pancreatic cancer	0.000405	0.00075	CcSEcCtD
Cilazapril—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000403	0.000746	CcSEcCtD
Cilazapril—Hypotension—Docetaxel—pancreatic cancer	0.000401	0.000744	CcSEcCtD
Cilazapril—Urethral disorder—Epirubicin—pancreatic cancer	0.0004	0.000741	CcSEcCtD
Cilazapril—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000397	0.000737	CcSEcCtD
Cilazapril—Epistaxis—Doxorubicin—pancreatic cancer	0.000396	0.000735	CcSEcCtD
Cilazapril—Vomiting—Irinotecan—pancreatic cancer	0.000395	0.000732	CcSEcCtD
Cilazapril—Sinusitis—Doxorubicin—pancreatic cancer	0.000394	0.000731	CcSEcCtD
Cilazapril—Dizziness—Fluorouracil—pancreatic cancer	0.000393	0.000729	CcSEcCtD
Cilazapril—Visual impairment—Epirubicin—pancreatic cancer	0.000393	0.000728	CcSEcCtD
Cilazapril—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000392	0.000727	CcSEcCtD
Cilazapril—Rash—Irinotecan—pancreatic cancer	0.000392	0.000726	CcSEcCtD
Cilazapril—Dermatitis—Irinotecan—pancreatic cancer	0.000391	0.000725	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000391	0.000725	CcSEcCtD
Cilazapril—Headache—Irinotecan—pancreatic cancer	0.000389	0.000721	CcSEcCtD
Cilazapril—Insomnia—Docetaxel—pancreatic cancer	0.000388	0.00072	CcSEcCtD
Cilazapril—Paraesthesia—Docetaxel—pancreatic cancer	0.000386	0.000715	CcSEcCtD
Cilazapril—Erythema multiforme—Epirubicin—pancreatic cancer	0.000385	0.000715	CcSEcCtD
Cilazapril—Vomiting—Gemcitabine—pancreatic cancer	0.000385	0.000713	CcSEcCtD
Cilazapril—Bradycardia—Doxorubicin—pancreatic cancer	0.000384	0.000712	CcSEcCtD
Cilazapril—Dyspnoea—Docetaxel—pancreatic cancer	0.000383	0.00071	CcSEcCtD
Cilazapril—Somnolence—Docetaxel—pancreatic cancer	0.000382	0.000708	CcSEcCtD
Cilazapril—Rash—Gemcitabine—pancreatic cancer	0.000382	0.000707	CcSEcCtD
Cilazapril—Dermatitis—Gemcitabine—pancreatic cancer	0.000381	0.000707	CcSEcCtD
Cilazapril—Tinnitus—Epirubicin—pancreatic cancer	0.00038	0.000705	CcSEcCtD
Cilazapril—Headache—Gemcitabine—pancreatic cancer	0.000379	0.000703	CcSEcCtD
Cilazapril—Cardiac disorder—Epirubicin—pancreatic cancer	0.000378	0.000701	CcSEcCtD
Cilazapril—Flushing—Epirubicin—pancreatic cancer	0.000378	0.000701	CcSEcCtD
Cilazapril—Vomiting—Fluorouracil—pancreatic cancer	0.000378	0.000701	CcSEcCtD
Cilazapril—Rhinitis—Doxorubicin—pancreatic cancer	0.000378	0.000701	CcSEcCtD
Cilazapril—Dyspepsia—Docetaxel—pancreatic cancer	0.000378	0.000701	CcSEcCtD
Cilazapril—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000375	0.000696	CcSEcCtD
Cilazapril—Rash—Fluorouracil—pancreatic cancer	0.000375	0.000695	CcSEcCtD
Cilazapril—Dermatitis—Fluorouracil—pancreatic cancer	0.000375	0.000695	CcSEcCtD
Cilazapril—Pharyngitis—Doxorubicin—pancreatic cancer	0.000374	0.000694	CcSEcCtD
Cilazapril—Decreased appetite—Docetaxel—pancreatic cancer	0.000373	0.000692	CcSEcCtD
Cilazapril—Headache—Fluorouracil—pancreatic cancer	0.000373	0.000691	CcSEcCtD
Cilazapril—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000373	0.000691	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000371	0.000687	CcSEcCtD
Cilazapril—Fatigue—Docetaxel—pancreatic cancer	0.00037	0.000686	CcSEcCtD
Cilazapril—Angiopathy—Epirubicin—pancreatic cancer	0.00037	0.000686	CcSEcCtD
Cilazapril—Urethral disorder—Doxorubicin—pancreatic cancer	0.00037	0.000686	CcSEcCtD
Cilazapril—Nausea—Irinotecan—pancreatic cancer	0.000369	0.000684	CcSEcCtD
Cilazapril—Immune system disorder—Epirubicin—pancreatic cancer	0.000368	0.000683	CcSEcCtD
Cilazapril—Constipation—Docetaxel—pancreatic cancer	0.000367	0.000681	CcSEcCtD
Cilazapril—Pain—Docetaxel—pancreatic cancer	0.000367	0.000681	CcSEcCtD
Cilazapril—Chills—Epirubicin—pancreatic cancer	0.000366	0.000678	CcSEcCtD
Cilazapril—Arrhythmia—Epirubicin—pancreatic cancer	0.000364	0.000675	CcSEcCtD
Cilazapril—Visual impairment—Doxorubicin—pancreatic cancer	0.000364	0.000674	CcSEcCtD
Cilazapril—Alopecia—Epirubicin—pancreatic cancer	0.00036	0.000668	CcSEcCtD
Cilazapril—Nausea—Gemcitabine—pancreatic cancer	0.000359	0.000666	CcSEcCtD
Cilazapril—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000357	0.000661	CcSEcCtD
Cilazapril—Feeling abnormal—Docetaxel—pancreatic cancer	0.000354	0.000656	CcSEcCtD
Cilazapril—Nausea—Fluorouracil—pancreatic cancer	0.000353	0.000655	CcSEcCtD
Cilazapril—Tinnitus—Doxorubicin—pancreatic cancer	0.000352	0.000652	CcSEcCtD
Cilazapril—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000351	0.000651	CcSEcCtD
Cilazapril—Cardiac disorder—Doxorubicin—pancreatic cancer	0.00035	0.000649	CcSEcCtD
Cilazapril—Flushing—Doxorubicin—pancreatic cancer	0.00035	0.000649	CcSEcCtD
Cilazapril—Flatulence—Epirubicin—pancreatic cancer	0.00035	0.000648	CcSEcCtD
Cilazapril—Tension—Epirubicin—pancreatic cancer	0.000348	0.000646	CcSEcCtD
Cilazapril—Dysgeusia—Epirubicin—pancreatic cancer	0.000348	0.000644	CcSEcCtD
Cilazapril—Nervousness—Epirubicin—pancreatic cancer	0.000345	0.000639	CcSEcCtD
Cilazapril—Angiopathy—Doxorubicin—pancreatic cancer	0.000342	0.000634	CcSEcCtD
Cilazapril—Muscle spasms—Epirubicin—pancreatic cancer	0.000341	0.000633	CcSEcCtD
Cilazapril—Immune system disorder—Doxorubicin—pancreatic cancer	0.000341	0.000632	CcSEcCtD
Cilazapril—Abdominal pain—Docetaxel—pancreatic cancer	0.000339	0.000629	CcSEcCtD
Cilazapril—Chills—Doxorubicin—pancreatic cancer	0.000338	0.000627	CcSEcCtD
Cilazapril—Arrhythmia—Doxorubicin—pancreatic cancer	0.000337	0.000625	CcSEcCtD
Cilazapril—Alopecia—Doxorubicin—pancreatic cancer	0.000333	0.000618	CcSEcCtD
Cilazapril—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000329	0.00061	CcSEcCtD
Cilazapril—Anaemia—Epirubicin—pancreatic cancer	0.000328	0.000608	CcSEcCtD
Cilazapril—Flatulence—Doxorubicin—pancreatic cancer	0.000324	0.0006	CcSEcCtD
Cilazapril—Tension—Doxorubicin—pancreatic cancer	0.000322	0.000597	CcSEcCtD
Cilazapril—Dysgeusia—Doxorubicin—pancreatic cancer	0.000322	0.000596	CcSEcCtD
Cilazapril—Malaise—Epirubicin—pancreatic cancer	0.00032	0.000593	CcSEcCtD
Cilazapril—Nervousness—Doxorubicin—pancreatic cancer	0.000319	0.000591	CcSEcCtD
Cilazapril—Vertigo—Epirubicin—pancreatic cancer	0.000319	0.000591	CcSEcCtD
Cilazapril—Syncope—Epirubicin—pancreatic cancer	0.000318	0.00059	CcSEcCtD
Cilazapril—Leukopenia—Epirubicin—pancreatic cancer	0.000318	0.000589	CcSEcCtD
Cilazapril—Hypersensitivity—Docetaxel—pancreatic cancer	0.000316	0.000587	CcSEcCtD
Cilazapril—Muscle spasms—Doxorubicin—pancreatic cancer	0.000316	0.000585	CcSEcCtD
Cilazapril—Palpitations—Epirubicin—pancreatic cancer	0.000314	0.000581	CcSEcCtD
Cilazapril—Loss of consciousness—Epirubicin—pancreatic cancer	0.000312	0.000578	CcSEcCtD
Cilazapril—Cough—Epirubicin—pancreatic cancer	0.00031	0.000574	CcSEcCtD
Cilazapril—Asthenia—Docetaxel—pancreatic cancer	0.000308	0.000571	CcSEcCtD
Cilazapril—Hypertension—Epirubicin—pancreatic cancer	0.000306	0.000568	CcSEcCtD
Cilazapril—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000305	0.000565	CcSEcCtD
Cilazapril—Pruritus—Docetaxel—pancreatic cancer	0.000304	0.000563	CcSEcCtD
Cilazapril—Anaemia—Doxorubicin—pancreatic cancer	0.000304	0.000563	CcSEcCtD
Cilazapril—Arthralgia—Epirubicin—pancreatic cancer	0.000302	0.00056	CcSEcCtD
Cilazapril—Chest pain—Epirubicin—pancreatic cancer	0.000302	0.00056	CcSEcCtD
Cilazapril—Myalgia—Epirubicin—pancreatic cancer	0.000302	0.00056	CcSEcCtD
Cilazapril—Anxiety—Epirubicin—pancreatic cancer	0.000301	0.000558	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.0003	0.000556	CcSEcCtD
Cilazapril—Discomfort—Epirubicin—pancreatic cancer	0.000299	0.000553	CcSEcCtD
Cilazapril—Malaise—Doxorubicin—pancreatic cancer	0.000296	0.000549	CcSEcCtD
Cilazapril—Dry mouth—Epirubicin—pancreatic cancer	0.000296	0.000548	CcSEcCtD
Cilazapril—Vertigo—Doxorubicin—pancreatic cancer	0.000295	0.000547	CcSEcCtD
Cilazapril—Syncope—Doxorubicin—pancreatic cancer	0.000294	0.000546	CcSEcCtD
Cilazapril—Leukopenia—Doxorubicin—pancreatic cancer	0.000294	0.000545	CcSEcCtD
Cilazapril—Diarrhoea—Docetaxel—pancreatic cancer	0.000294	0.000545	CcSEcCtD
Cilazapril—Confusional state—Epirubicin—pancreatic cancer	0.000292	0.000541	CcSEcCtD
Cilazapril—Palpitations—Doxorubicin—pancreatic cancer	0.00029	0.000538	CcSEcCtD
Cilazapril—Oedema—Epirubicin—pancreatic cancer	0.00029	0.000537	CcSEcCtD
Cilazapril—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000289	0.000535	CcSEcCtD
Cilazapril—Cough—Doxorubicin—pancreatic cancer	0.000287	0.000531	CcSEcCtD
Cilazapril—Shock—Epirubicin—pancreatic cancer	0.000285	0.000528	CcSEcCtD
Cilazapril—Dizziness—Docetaxel—pancreatic cancer	0.000284	0.000526	CcSEcCtD
Cilazapril—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000284	0.000526	CcSEcCtD
Cilazapril—Hypertension—Doxorubicin—pancreatic cancer	0.000284	0.000526	CcSEcCtD
Cilazapril—Tachycardia—Epirubicin—pancreatic cancer	0.000283	0.000524	CcSEcCtD
Cilazapril—Skin disorder—Epirubicin—pancreatic cancer	0.000281	0.000522	CcSEcCtD
Cilazapril—Hyperhidrosis—Epirubicin—pancreatic cancer	0.00028	0.000519	CcSEcCtD
Cilazapril—Chest pain—Doxorubicin—pancreatic cancer	0.00028	0.000518	CcSEcCtD
Cilazapril—Arthralgia—Doxorubicin—pancreatic cancer	0.00028	0.000518	CcSEcCtD
Cilazapril—Myalgia—Doxorubicin—pancreatic cancer	0.00028	0.000518	CcSEcCtD
Cilazapril—Anxiety—Doxorubicin—pancreatic cancer	0.000279	0.000516	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000278	0.000515	CcSEcCtD
Cilazapril—Discomfort—Doxorubicin—pancreatic cancer	0.000276	0.000512	CcSEcCtD
Cilazapril—Anorexia—Epirubicin—pancreatic cancer	0.000276	0.000512	CcSEcCtD
Cilazapril—Dry mouth—Doxorubicin—pancreatic cancer	0.000273	0.000507	CcSEcCtD
Cilazapril—Vomiting—Docetaxel—pancreatic cancer	0.000273	0.000506	CcSEcCtD
Cilazapril—Rash—Docetaxel—pancreatic cancer	0.000271	0.000502	CcSEcCtD
Cilazapril—Hypotension—Epirubicin—pancreatic cancer	0.000271	0.000502	CcSEcCtD
Cilazapril—Dermatitis—Docetaxel—pancreatic cancer	0.000271	0.000501	CcSEcCtD
Cilazapril—Confusional state—Doxorubicin—pancreatic cancer	0.00027	0.000501	CcSEcCtD
Cilazapril—Headache—Docetaxel—pancreatic cancer	0.000269	0.000499	CcSEcCtD
Cilazapril—Oedema—Doxorubicin—pancreatic cancer	0.000268	0.000497	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000264	0.000489	CcSEcCtD
Cilazapril—Shock—Doxorubicin—pancreatic cancer	0.000264	0.000489	CcSEcCtD
Cilazapril—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000262	0.000486	CcSEcCtD
Cilazapril—Insomnia—Epirubicin—pancreatic cancer	0.000262	0.000486	CcSEcCtD
Cilazapril—Tachycardia—Doxorubicin—pancreatic cancer	0.000262	0.000485	CcSEcCtD
Cilazapril—Skin disorder—Doxorubicin—pancreatic cancer	0.00026	0.000483	CcSEcCtD
Cilazapril—Paraesthesia—Epirubicin—pancreatic cancer	0.00026	0.000482	CcSEcCtD
Cilazapril—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000259	0.00048	CcSEcCtD
Cilazapril—Dyspnoea—Epirubicin—pancreatic cancer	0.000258	0.000479	CcSEcCtD
Cilazapril—Somnolence—Epirubicin—pancreatic cancer	0.000258	0.000477	CcSEcCtD
Cilazapril—Anorexia—Doxorubicin—pancreatic cancer	0.000255	0.000474	CcSEcCtD
Cilazapril—Nausea—Docetaxel—pancreatic cancer	0.000255	0.000473	CcSEcCtD
Cilazapril—Dyspepsia—Epirubicin—pancreatic cancer	0.000255	0.000473	CcSEcCtD
Cilazapril—Decreased appetite—Epirubicin—pancreatic cancer	0.000252	0.000467	CcSEcCtD
Cilazapril—Hypotension—Doxorubicin—pancreatic cancer	0.00025	0.000464	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.00025	0.000464	CcSEcCtD
Cilazapril—Fatigue—Epirubicin—pancreatic cancer	0.00025	0.000463	CcSEcCtD
Cilazapril—Pain—Epirubicin—pancreatic cancer	0.000248	0.000459	CcSEcCtD
Cilazapril—Constipation—Epirubicin—pancreatic cancer	0.000248	0.000459	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000244	0.000453	CcSEcCtD
Cilazapril—Insomnia—Doxorubicin—pancreatic cancer	0.000242	0.000449	CcSEcCtD
Cilazapril—Paraesthesia—Doxorubicin—pancreatic cancer	0.000241	0.000446	CcSEcCtD
Cilazapril—Dyspnoea—Doxorubicin—pancreatic cancer	0.000239	0.000443	CcSEcCtD
Cilazapril—Feeling abnormal—Epirubicin—pancreatic cancer	0.000239	0.000442	CcSEcCtD
Cilazapril—Somnolence—Doxorubicin—pancreatic cancer	0.000238	0.000442	CcSEcCtD
Cilazapril—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000237	0.000439	CcSEcCtD
Cilazapril—Dyspepsia—Doxorubicin—pancreatic cancer	0.000236	0.000437	CcSEcCtD
Cilazapril—Decreased appetite—Doxorubicin—pancreatic cancer	0.000233	0.000432	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000231	0.000429	CcSEcCtD
Cilazapril—Fatigue—Doxorubicin—pancreatic cancer	0.000231	0.000428	CcSEcCtD
Cilazapril—Urticaria—Epirubicin—pancreatic cancer	0.00023	0.000427	CcSEcCtD
Cilazapril—Constipation—Doxorubicin—pancreatic cancer	0.000229	0.000425	CcSEcCtD
Cilazapril—Pain—Doxorubicin—pancreatic cancer	0.000229	0.000425	CcSEcCtD
Cilazapril—Abdominal pain—Epirubicin—pancreatic cancer	0.000229	0.000424	CcSEcCtD
Cilazapril—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000221	0.000409	CcSEcCtD
Cilazapril—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000219	0.000406	CcSEcCtD
Cilazapril—Hypersensitivity—Epirubicin—pancreatic cancer	0.000213	0.000396	CcSEcCtD
Cilazapril—Urticaria—Doxorubicin—pancreatic cancer	0.000213	0.000395	CcSEcCtD
Cilazapril—Abdominal pain—Doxorubicin—pancreatic cancer	0.000212	0.000393	CcSEcCtD
Cilazapril—Asthenia—Epirubicin—pancreatic cancer	0.000208	0.000385	CcSEcCtD
Cilazapril—Pruritus—Epirubicin—pancreatic cancer	0.000205	0.00038	CcSEcCtD
Cilazapril—Diarrhoea—Epirubicin—pancreatic cancer	0.000198	0.000367	CcSEcCtD
Cilazapril—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000197	0.000366	CcSEcCtD
Cilazapril—Asthenia—Doxorubicin—pancreatic cancer	0.000192	0.000356	CcSEcCtD
Cilazapril—Dizziness—Epirubicin—pancreatic cancer	0.000192	0.000355	CcSEcCtD
Cilazapril—Pruritus—Doxorubicin—pancreatic cancer	0.00019	0.000352	CcSEcCtD
Cilazapril—Vomiting—Epirubicin—pancreatic cancer	0.000184	0.000341	CcSEcCtD
Cilazapril—Diarrhoea—Doxorubicin—pancreatic cancer	0.000183	0.00034	CcSEcCtD
Cilazapril—Rash—Epirubicin—pancreatic cancer	0.000183	0.000339	CcSEcCtD
Cilazapril—Dermatitis—Epirubicin—pancreatic cancer	0.000182	0.000338	CcSEcCtD
Cilazapril—Headache—Epirubicin—pancreatic cancer	0.000181	0.000336	CcSEcCtD
Cilazapril—Dizziness—Doxorubicin—pancreatic cancer	0.000177	0.000329	CcSEcCtD
Cilazapril—Nausea—Epirubicin—pancreatic cancer	0.000172	0.000319	CcSEcCtD
Cilazapril—Vomiting—Doxorubicin—pancreatic cancer	0.00017	0.000316	CcSEcCtD
Cilazapril—Rash—Doxorubicin—pancreatic cancer	0.000169	0.000313	CcSEcCtD
Cilazapril—Dermatitis—Doxorubicin—pancreatic cancer	0.000169	0.000313	CcSEcCtD
Cilazapril—Headache—Doxorubicin—pancreatic cancer	0.000168	0.000311	CcSEcCtD
Cilazapril—Nausea—Doxorubicin—pancreatic cancer	0.000159	0.000295	CcSEcCtD
